GILD Today - Aug 06: Price Target Cut Sparks Drop

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

GILD Today - Aug 06: Price Target Cut Sparks Drop

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey here, your friendly neighborhood investor. I’ve been in the game for a while now, and today we’re talking about Gilead Sciences, or GILD for short. It wasn’t a great day for them, as the stock dipped about 1.06%.

So, what went down? GILD got smoked today, mainly because Morgan Stanley decided to lower their price target for the stock. That’s never a good look, right? It sent investors scrambling, and the stock felt the heat. The volume was pretty average, but it just wasn’t a good vibe all around.

Now, why did this happen? Well, the guidance update from Morgan Stanley caught everyone off guard. They’re saying that Gilead’s research and development efforts are facing some bumps, and that’s not what you want to hear. Sure, sales are holding up, but when the R&D news hits, it makes folks nervous. Plus, it seems like Gilead’s been underperforming compared to its competitors lately, which doesn’t help. People are always looking for the next big thing, and if Gilead isn’t delivering, they might just hit the sell button fast.

One interesting tidbit? Gilead recently raised its HIV guidance on their Q2 earnings call. That’s a big deal because it shows they’re still making moves in that area, even if the stock price isn’t reflecting it today.

So, yeah, that’s the scoop on GILD for today. Just remember, I’m here to share info and keep it light, not to give any financial advice. Let’s see how it all plays out! Catch you later!

まだレビューはありません